Reaction

Disseminated Varicella Zoster Virus Infection reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 348 reports · 14 co-occurring drugs

As of the last recalculation, Disseminated Varicella Zoster Virus Infection appears in 348 FAERS reports alongside 14 co-occurring drug terms. The strongest observed disproportionality signal is MYCOPHENOLATE MOFETIL HYDROCHLORIDE (PRR 79.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Mycophenolate Mofetil Hydrochloride11979.079.0
Mycophenolate Mofetil11878.178.2
Valganciclovir Hydrochloride Powder,1366.266.3
Valganciclovir1963.763.8
Valganciclovir Hydrochloride1963.763.8
Thiotepa851.351.3
Sirolimus1045.745.7
Tacrolimus Ointment 0.1%7545.645.7
Tacrolimus Extended-Release Capsules7545.545.5
Bendamustine Hcl935.635.6
Daratumumab1930.030.0
Belimumab1325.525.5
Baricitinib425.125.1
Carfilzomib919.519.5

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.